A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 82 shares of BIO stock, worth $27,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82
Previous 1,836 95.53%
Holding current value
$27,755
Previous $501,000 94.61%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $463,003 - $604,498
-1,754 Reduced 95.53%
82 $27,000
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $492,525 - $623,285
1,836 New
1,836 $501,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.34B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.